RUNX2 and cleidocranial dysplasia 1: The loss of the positively charged arginine residue destabilizes the protein structure and disrupts its interaction with other transcription factors (10), confirming the diagnosis of cleidocranial dysplasia (CCD) secondary to a heterozygous RUNX2 mutation.